CN1272038C - 治疗妇女慢性宫颈炎的中药栓剂的制备方法 - Google Patents
治疗妇女慢性宫颈炎的中药栓剂的制备方法 Download PDFInfo
- Publication number
- CN1272038C CN1272038C CN 200510018254 CN200510018254A CN1272038C CN 1272038 C CN1272038 C CN 1272038C CN 200510018254 CN200510018254 CN 200510018254 CN 200510018254 A CN200510018254 A CN 200510018254A CN 1272038 C CN1272038 C CN 1272038C
- Authority
- CN
- China
- Prior art keywords
- share
- present
- chronic cervicitis
- preparation
- suppository
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010008323 cervicitis Diseases 0.000 title claims abstract description 16
- 201000003988 chronic cervicitis Diseases 0.000 title claims abstract description 16
- 239000000829 suppository Substances 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title description 11
- 239000003814 drug Substances 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- 125000005456 glyceride group Chemical group 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims 1
- 230000003628 erosive effect Effects 0.000 abstract description 10
- 239000000758 substrate Substances 0.000 abstract description 10
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 239000004166 Lanolin Substances 0.000 abstract 1
- 235000003893 Prunus dulcis var amara Nutrition 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 229940039717 lanolin Drugs 0.000 abstract 1
- 235000019388 lanolin Nutrition 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 5
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000005242 forging Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 238000005325 percolation Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 241000223229 Trichophyton rubrum Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940089837 amygdalin Drugs 0.000 description 2
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 2
- 239000003716 antitrichomonal agent Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241001147468 Chondrus ocellatus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- -1 oxymatrine Chemical compound 0.000 description 1
- 230000000590 parasiticidal effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 229940120293 vaginal suppository Drugs 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510018254 CN1272038C (zh) | 2005-02-02 | 2005-02-02 | 治疗妇女慢性宫颈炎的中药栓剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510018254 CN1272038C (zh) | 2005-02-02 | 2005-02-02 | 治疗妇女慢性宫颈炎的中药栓剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1679755A CN1679755A (zh) | 2005-10-12 |
CN1272038C true CN1272038C (zh) | 2006-08-30 |
Family
ID=35066761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510018254 Active CN1272038C (zh) | 2005-02-02 | 2005-02-02 | 治疗妇女慢性宫颈炎的中药栓剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1272038C (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE29506458U1 (de) * | 1995-04-15 | 1995-07-06 | Leitz Geb Gmbh & Co | Messerkopf, insbesondere Hobelmesserkopf |
CN100396292C (zh) * | 2006-08-05 | 2008-06-25 | 张德惠 | 一种治疗宫颈糜烂的中药粉剂 |
CN102028652B (zh) * | 2010-11-29 | 2012-10-10 | 林凡友 | 一种硝酸芬替康唑栓剂的制备方法 |
CN102764319A (zh) * | 2012-08-13 | 2012-11-07 | 广西康华药业有限责任公司 | 治疗妇女宫颈糜烂的中药阴道泡腾片及其制备方法 |
CN103494908B (zh) * | 2013-10-11 | 2015-10-28 | 哈尔滨欧替药业有限公司 | 治疗宫颈糜烂、附件炎的阴道膨胀栓及其制备方法和检测方法 |
CN104606226B (zh) * | 2015-02-27 | 2017-12-05 | 赵树生 | 抗菌消炎中药栓剂及其制备方法和质控方法 |
CN109044961A (zh) * | 2018-09-29 | 2018-12-21 | 江西九华药业有限公司 | 一种复方小儿退热栓及其制备方法 |
CN109223705A (zh) * | 2018-10-09 | 2019-01-18 | 杨世林 | 苦参碱肛门栓及其制备方法和用途 |
-
2005
- 2005-02-02 CN CN 200510018254 patent/CN1272038C/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN1679755A (zh) | 2005-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1272038C (zh) | 治疗妇女慢性宫颈炎的中药栓剂的制备方法 | |
CN101049415A (zh) | 一种治疗妇科炎症的中药组合物 | |
CN1883618A (zh) | 一种祖师麻有效部位及其制备方法与应用 | |
CN1879831A (zh) | 用于抑菌与治疗妇科炎症的外用制剂及其制备方法 | |
CN101874809A (zh) | 一种使用甘油dmso混合溶剂的局部抗炎外用药物组合物 | |
CN1709243A (zh) | 含有依布硒啉的阴道内使用药物及其用途 | |
CN1879710A (zh) | 大黄硫黄凝胶剂的制备方法 | |
CN101288754B (zh) | 一种护月宝制剂 | |
CN115837046A (zh) | 一种奥硝唑阴道栓剂及其制备方法 | |
CN1251748C (zh) | 治疗妇科疾病的洗剂及其制备方法 | |
CN1284585C (zh) | 治疗急慢性咽喉炎、复发性口腔溃疡的药物及制备方法 | |
CN101053612A (zh) | 妇科外用的中药洁阴剂及其洁阴凝膏 | |
CN109289000A (zh) | 一种治疗妇科炎症凝胶及其制备方法 | |
CN1824204A (zh) | 一种治疗急性痛风性关节炎的药物组合物及其制备方法 | |
CN1589793A (zh) | 鞣酸小檗碱在制备治疗溃疡性结肠炎药物中的应用 | |
CN102846750B (zh) | 风痛宁复合制剂及其制备方法 | |
CN1879654A (zh) | 一种抗菌消炎止痛生肌药物及其制备方法和用途 | |
CN1076864A (zh) | 康肤液 | |
CN1785264A (zh) | 一种用于治疗淋证的中药组合物及其口服液、片剂及胶囊剂的制备方法 | |
CN1255097C (zh) | 复方莪术油软膏及其制备方法 | |
CN100423735C (zh) | 一种治疗痔疮的中药 | |
CN102764319A (zh) | 治疗妇女宫颈糜烂的中药阴道泡腾片及其制备方法 | |
CN1282479C (zh) | 一种治疗口腔粘膜病的药物组合物及其制备方法 | |
CN1289110C (zh) | 治疗妇科疾病的胶囊制剂及其制备工艺 | |
CN1233313C (zh) | 喉症丸在制备外用治疗痤疮的凝胶剂中的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of Chinese medicinal suppository for treating female chronic cervicitis Effective date of registration: 20180403 Granted publication date: 20060830 Pledgee: Nanning Yongning District Rural Credit Cooperative Association high tech credit cooperative Pledgor: Guangxi Konwa Pharmaceutical Co.,Ltd. Registration number: 2018450000009 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200724 Granted publication date: 20060830 Pledgee: Nanning Yongning District Rural Credit Cooperative Association high tech credit cooperative Pledgor: GUANGXI KONWA PHARMACEUTICAL Co.,Ltd. Registration number: 2018450000009 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210202 Address after: 545000 comprehensive preparation building, 74 Hongguang Road, Liuzhou City, Guangxi Zhuang Autonomous Region Patentee after: Guangxi Huahong Jinrui Pharmaceutical Co.,Ltd. Address before: 530003, 58 Garden Avenue, Nanning, the Guangxi Zhuang Autonomous Region Patentee before: GUANGXI KONWA PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230810 Address after: 545199 no.529, Liubao Road, Liujiang District, Liuzhou City, Guangxi Zhuang Autonomous Region Patentee after: Huahong Pharmaceutical Group Co.,Ltd. of Guangxi Zhuang Autonomous Region Address before: 545000 comprehensive preparation building, 74 Hongguang Road, Liuzhou City, Guangxi Zhuang Autonomous Region Patentee before: Guangxi Huahong Jinrui Pharmaceutical Co.,Ltd. |